Free Trial

AMCI Acquisition (AMCI) Financials

AMCI Acquisition logo
$2.59 -0.19 (-6.83%)
As of 02:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for AMCI Acquisition

Annual Income Statements for AMCI Acquisition

This table shows AMCI Acquisition's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-0.04 2.90 -0.78 -25
Consolidated Net Income / (Loss)
-0.04 2.90 -0.78 -25
Net Income / (Loss) Continuing Operations
-0.04 2.90 -0.78 -25
Total Pre-Tax Income
-0.04 2.90 -0.77 -25
Total Operating Income
-0.08 -0.68 -2.55 -0.51
Total Gross Profit
0.00 0.00 0.66 2.85
Total Revenue
0.00 0.00 10 5.98
Operating Revenue
- - 10 5.98
Total Cost of Revenue
0.00 0.00 9.54 3.13
Operating Cost of Revenue
- - 9.54 3.13
Total Operating Expenses
0.08 0.68 3.21 3.36
Selling, General & Admin Expense
0.08 0.68 2.19 2.69
Marketing Expense
- - 2.03 0.61
Research & Development Expense
- - 0.26 0.06
Other Operating Expenses / (Income)
- - -1.26 0.00
Impairment Charge
- - 0.00 0.00
Total Other Income / (Expense), net
0.04 3.58 1.78 -24
Interest Expense
- - 0.03 0.02
Interest & Investment Income
0.04 3.58 0.00 0.01
Other Income / (Expense), net
0.00 0.00 1.81 -24
Income Tax Expense
- - 0.01 0.00
Basic Earnings per Share
$0.12 $0.36 ($0.04) ($1.36)
Weighted Average Basic Shares Outstanding
2.05M 9.15M 18M 18.29M
Diluted Earnings per Share
$0.12 $0.36 ($0.04) ($1.36)
Weighted Average Diluted Shares Outstanding
2.05M 9.15M 18M 18.29M

Quarterly Income Statements for AMCI Acquisition

This table shows AMCI Acquisition's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
0.80 0.35 0.38 0.50 -2.01 -0.08 -0.23 -2.65 -22 0.15 -0.18
Consolidated Net Income / (Loss)
0.80 0.35 0.38 0.50 -2.01 -0.08 -0.23 -2.65 -22 0.15 -0.18
Net Income / (Loss) Continuing Operations
0.80 0.35 0.38 0.50 -2.01 -0.08 -0.23 -2.65 -22 0.15 -0.18
Total Pre-Tax Income
0.80 0.35 0.38 0.50 -2.00 -0.07 -0.23 -2.65 -22 0.15 -0.18
Total Operating Income
-0.19 -0.24 -0.15 -0.18 -1.99 -0.75 -0.74 -2.82 2.66 0.13 -0.16
Total Gross Profit
- 0.00 0.00 0.00 0.66 0.49 0.27 0.00 2.85 1.02 0.75
Total Revenue
- 0.00 0.00 0.00 10 1.79 1.40 0.00 5.98 1.18 0.94
Operating Revenue
- - - - - 1.79 1.40 - - 1.18 0.94
Total Cost of Revenue
- 0.00 0.00 0.00 9.54 1.30 1.13 0.00 3.13 0.16 0.19
Operating Cost of Revenue
- - - - - 1.30 1.13 - - 0.16 0.19
Total Operating Expenses
0.19 0.24 0.15 0.18 2.64 1.24 1.00 2.82 0.20 0.89 0.91
Selling, General & Admin Expense
0.19 0.24 0.15 0.18 1.62 0.82 0.78 2.82 -0.48 0.85 0.88
Marketing Expense
- - - - - 0.40 0.21 - - 0.01 0.02
Research & Development Expense
- - - - - 0.01 0.01 - - 0.02 0.00
Impairment Charge
- - - - - 0.00 0.00 - - 0.00 0.00
Total Other Income / (Expense), net
0.99 0.59 0.53 0.68 -0.02 0.67 0.51 0.17 -25 0.02 -0.02
Interest Expense
- - - - - 0.02 0.01 - - 0.00 0.00
Interest & Investment Income
0.99 0.59 0.53 0.68 -1.80 0.00 0.00 0.17 -0.53 0.03 0.03
Other Income / (Expense), net
- 0.00 0.00 0.00 1.81 0.69 0.52 0.00 -24 -0.01 -0.05
Income Tax Expense
- - - - - 0.00 0.00 - - 0.00 -0.00
Basic Earnings per Share
$0.08 $0.05 $0.06 $0.07 ($0.22) $0.00 ($0.01) ($1.36) ($0.09) $0.01 ($0.01)
Weighted Average Basic Shares Outstanding
9.15M 7.01M 7.01M 7.01M 18M 18M 18M 3.85M 18.29M 22.60M 22.60M
Diluted Earnings per Share
$0.08 $0.05 $0.06 $0.07 ($0.22) $0.00 ($0.01) ($1.36) ($0.09) $0.01 ($0.01)
Weighted Average Diluted Shares Outstanding
9.15M 7.01M 7.01M 7.01M 18M 18M 18M 3.85M 18.29M 24.81M 22.60M
Weighted Average Basic & Diluted Shares Outstanding
0.00 7.01M 7.01M 7.01M 0.00 3.85M 3.85M 3.22M 0.00 22.60M 22.60M

Annual Cash Flow Statements for AMCI Acquisition

This table details how cash moves in and out of AMCI Acquisition's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.66 -0.63 0.23 6.65
Net Cash From Operating Activities
0.00 -0.63 0.57 -5.56
Net Cash From Continuing Operating Activities
0.00 -0.63 0.57 -5.56
Net Income / (Loss) Continuing Operations
-0.04 2.90 -0.78 -25
Consolidated Net Income / (Loss)
-0.04 2.90 -0.78 -25
Non-Cash Adjustments To Reconcile Net Income
-0.00 -3.58 1.31 27
Changes in Operating Assets and Liabilities, net
0.05 0.05 0.04 -8.00
Net Cash From Investing Activities
-70 23 -0.19 0.02
Net Cash From Continuing Investing Activities
-70 23 -0.19 0.02
Other Investing Activities, net
0.00 23 -0.19 0.02
Net Cash From Financing Activities
71 -23 -0.15 12
Net Cash From Continuing Financing Activities
71 -23 -0.15 12
Repayment of Debt
- - -2.17 -0.82
Repurchase of Common Equity
-0.54 - -0.23 -0.59
Issuance of Debt
0.00 0.17 2.18 0.00
Issuance of Common Equity
62 - 0.00 8.00
Other Financing Activities, net
9.18 -23 0.08 5.60
Effect of Exchange Rate Changes
- - 0.00 0.01
Cash Interest Paid
- - 0.02 0.02
Cash Income Taxes Paid
- - 0.04 0.00

Quarterly Cash Flow Statements for AMCI Acquisition

This table details how cash moves in and out of AMCI Acquisition's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-0.03 -0.01 0.00 -0.01 0.25 -0.10 - -0.00 6.65 -0.37 -2.09
Net Cash From Operating Activities
-0.03 -0.01 0.00 -0.01 0.59 0.20 - -0.00 -5.56 -0.39 -1.09
Net Cash From Continuing Operating Activities
-0.03 -0.01 0.00 -0.01 0.59 0.20 - -0.00 -5.56 -0.39 -1.09
Net Income / (Loss) Continuing Operations
0.80 0.35 0.38 0.50 -2.01 -0.08 0.02 -2.65 -22 0.15 -0.18
Consolidated Net Income / (Loss)
0.80 0.35 0.38 0.50 -2.01 -0.08 0.02 -2.65 -22 0.15 -0.18
Non-Cash Adjustments To Reconcile Net Income
-0.99 -0.59 -0.53 -0.68 3.11 -0.02 -0.19 2.28 25 0.31 -1.00
Changes in Operating Assets and Liabilities, net
0.16 0.22 0.15 0.18 -0.51 0.30 0.16 0.37 -8.71 -0.85 0.09
Net Cash From Investing Activities
23 -0.06 -0.11 -0.22 0.20 -0.31 -0.17 - 0.40 0.00 -1.00
Net Cash From Continuing Investing Activities
23 -0.06 -0.11 -0.22 0.20 -0.31 -0.17 - 0.40 0.00 -1.00
Effect of Exchange Rate Changes
- - - - - 0.00 - - - -0.00 -0.00
Cash Income Taxes Paid
- - - - - 0.00 - - - 0.00 0.00

Annual Balance Sheets for AMCI Acquisition

This table presents AMCI Acquisition's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
71 51 7.35 11
Total Current Assets
0.74 0.06 7.22 11
Cash & Equivalents
0.66 0.03 0.36 7.00
Accounts Receivable
- - 2.33 2.54
Inventories, net
- - 3.56 1.07
Prepaid Expenses
0.08 0.03 0.10 0.36
Other Current Assets
- 0.00 0.86 0.09
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00
Total Noncurrent Assets
70 51 0.13 0.12
Long-Term Investments
70 - - 0.00
Other Noncurrent Operating Assets
0.03 51 0.13 0.12
Total Liabilities & Shareholders' Equity
71 51 7.35 11
Total Liabilities
0.26 0.39 9.68 0.86
Total Current Liabilities
0.26 0.39 9.67 0.80
Accounts Payable
0.25 0.21 8.54 0.00
Accrued Expenses
- - 0.29 0.73
Current Deferred & Payable Income Tax Liabilities
- - 0.01 0.01
Other Current Liabilities
0.01 0.01 0.01 0.06
Total Noncurrent Liabilities
0.00 0.00 0.01 0.06
Other Noncurrent Operating Liabilities
- - 0.01 0.06
Commitments & Contingencies
0.00 0.00 - 0.00
Total Equity & Noncontrolling Interests
0.55 -0.32 -2.33 10
Total Preferred & Common Equity
0.55 -0.32 -2.33 10
Total Common Equity
0.55 -0.32 -2.33 10
Common Stock
0.60 0.00 0.14 38
Retained Earnings
-0.04 -0.33 -2.47 -27
Accumulated Other Comprehensive Income / (Loss)
- - -0.01 0.00

Quarterly Balance Sheets for AMCI Acquisition

This table presents AMCI Acquisition's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
73 52 52 53 18 19 19 11 11
Total Current Assets
0.11 0.09 0.07 0.03 0.07 0.05 0.03 11 10
Cash & Equivalents
0.06 0.01 0.01 0.01 0.00 0.00 0.00 6.63 4.54
Accounts Receivable
- - - - - - - 3.31 3.47
Inventories, net
- - - - - - - 0.91 0.77
Prepaid Expenses
0.05 0.08 0.06 0.02 0.07 0.04 0.02 0.27 0.24
Other Current Assets
- - - - - - - 0.08 1.12
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets
73 52 52 53 18 19 19 0.10 1.08
Long-Term Investments
- 51 52 53 18 19 - - 1.00
Other Noncurrent Operating Assets
73 0.06 0.17 0.06 0.00 0.00 19 0.10 0.08
Total Liabilities & Shareholders' Equity
73 52 52 53 18 19 19 11 11
Total Liabilities
0.08 0.71 0.94 1.31 2.16 2.47 5.26 0.82 0.92
Total Current Liabilities
0.08 0.71 0.94 1.31 2.16 2.47 5.26 0.77 0.89
Accounts Payable
0.07 0.41 0.39 0.35 0.53 0.61 0.90 0.00 0.00
Accrued Expenses
- - - - - - 2.42 0.70 0.82
Current Deferred & Payable Income Tax Liabilities
- - - - - - - 0.01 0.01
Other Current Liabilities
0.01 0.01 0.01 0.01 0.01 0.01 0.05 0.06 0.06
Total Noncurrent Liabilities
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.03
Other Noncurrent Operating Liabilities
- - - - - - - 0.04 0.03
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Total Equity & Noncontrolling Interests
0.03 -0.62 -0.87 -1.28 -2.09 -2.42 -5.24 10 10
Total Preferred & Common Equity
0.03 -0.62 -0.87 -1.28 -2.09 -2.42 -5.24 10 10
Total Common Equity
0.03 -0.62 -0.87 -1.28 -2.09 -2.42 -5.24 10 10
Common Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 38 38
Retained Earnings
0.03 -0.62 -0.87 -1.28 -2.09 -2.42 -5.24 -27 -27
Accumulated Other Comprehensive Income / (Loss)
- - - - - - - -0.00 -0.00

Annual Metrics And Ratios for AMCI Acquisition

This table displays calculated financial ratios and metrics derived from AMCI Acquisition's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 9,180,500.00 7,006,329.00 3,220,947.00
DEI Adjusted Shares Outstanding
0.00 9,180,500.00 7,006,329.00 3,220,947.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.32 -0.11 -7.71
Growth Metrics
- - - -
Revenue Growth
0.00% 0.00% 0.00% -41.37%
EBITDA Growth
0.00% -736.97% -9.84% -3,238.03%
EBIT Growth
0.00% -736.97% -9.84% -3,238.03%
NOPAT Growth
0.00% -1,095.66% -164.34% 80.22%
Net Income Growth
0.00% 6,920.83% -126.75% -3,094.16%
EPS Growth
0.00% 200.00% -111.11% -3,300.00%
Operating Cash Flow Growth
0.00% 0.00% 190.16% -1,077.36%
Free Cash Flow Firm Growth
0.00% 0.00% 198.57% -110.90%
Invested Capital Growth
0.00% 35,618.65% -103.69% 277.28%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 1.74% -615.19%
EBIT Q/Q Growth
0.00% 0.00% 1.74% -615.19%
NOPAT Q/Q Growth
0.00% 0.00% -136.47% 85.43%
Net Income Q/Q Growth
0.00% 0.00% -138.22% -1,058.43%
EPS Q/Q Growth
0.00% 0.00% -115.38% -14.29%
Operating Cash Flow Q/Q Growth
0.00% -4.87% 1,220.15% -10,863.38%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 69.75%
Invested Capital Q/Q Growth
0.00% 0.00% -568.17% -78.75%
Profitability Metrics
- - - -
Gross Margin
0.00% 0.00% 6.43% 47.70%
EBITDA Margin
0.00% 0.00% -7.28% -414.61%
Operating Margin
0.00% 0.00% -25.04% -8.45%
EBIT Margin
0.00% 0.00% -7.28% -414.61%
Profit (Net Income) Margin
0.00% 0.00% -7.62% -414.95%
Tax Burden Percent
100.00% 100.00% 101.02% 100.02%
Interest Burden Percent
52.69% -429.41% 103.54% 100.06%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% -7.32% -48.98%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 329.88% 698.98%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 4.10% -572.58%
Return on Equity (ROE)
-0.06% 4.78% -3.22% -621.56%
Cash Return on Invested Capital (CROIC)
0.00% -101.62% 0.00% -167.08%
Operating Return on Assets (OROA)
0.00% 0.00% -2.55% -267.76%
Return on Assets (ROA)
0.00% 0.00% -2.67% -267.97%
Return on Common Equity (ROCE)
0.00% 0.01% 0.18% -621.56%
Return on Equity Simple (ROE_SIMPLE)
-7.68% -894.08% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.06 -0.68 -1.79 -0.35
NOPAT Margin
0.00% 0.00% -17.53% -5.91%
Net Nonoperating Expense Percent (NNEP)
0.02% 10.09% -337.20% -747.95%
Return On Investment Capital (ROIC_SIMPLE)
- 423.17% 118.42% -3.43%
Cost of Revenue to Revenue
0.00% 0.00% 93.57% 52.30%
SG&A Expenses to Revenue
0.00% 0.00% 21.47% 44.93%
R&D to Revenue
0.00% 0.00% 2.50% 0.97%
Operating Expenses to Revenue
0.00% 0.00% 31.47% 56.15%
Earnings before Interest and Taxes (EBIT)
-0.08 -0.68 -0.74 -25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.08 -0.68 -0.74 -25
Valuation Ratios
- - - -
Price to Book Value (P/BV)
108.20 0.00 0.00 2.47
Price to Tangible Book Value (P/TBV)
108.20 0.00 0.00 2.47
Price to Revenue (P/Rev)
0.00 0.00 7.83 4.26
Price to Earnings (P/E)
0.00 33.86 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 2.95% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 2.95 0.00 5.58
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 7.88 3.09
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 141.32 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 1.58 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.00 0.00 -0.35 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00
Financial Leverage
-1.00 -0.58 0.01 -0.82
Leverage Ratio
1.00 1.01 1.21 2.32
Compound Leverage Factor
0.53 -4.32 1.25 2.32
Debt to Total Capital
0.00% 0.33% -54.45% 0.00%
Short-Term Debt to Total Capital
0.00% 0.33% -54.45% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
99.22% 100.32% 0.00% 0.00%
Common Equity to Total Capital
0.78% -0.64% 154.45% 100.00%
Debt to EBITDA
0.00 -0.24 -1.11 0.00
Net Debt to EBITDA
0.00 -0.20 -0.62 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 -0.24 -0.46 0.00
Net Debt to NOPAT
0.00 -0.20 -0.26 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00
Altman Z-Score
139.61 152.00 5.13 8.76
Noncontrolling Interest Sharing Ratio
99.22% 99.81% 105.51% 0.00%
Liquidity Ratios
- - - -
Current Ratio
2.88 0.16 0.75 13.89
Quick Ratio
2.56 0.07 0.28 12.00
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 -52 51 -5.53
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 1,884.53 -224.84
Operating Cash Flow to Interest Expense
0.00 0.00 21.10 -225.70
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 21.10 -225.70
Efficiency Ratios
- - - -
Asset Turnover
0.00 0.00 0.35 0.65
Accounts Receivable Turnover
0.00 0.00 0.00 2.46
Inventory Turnover
0.00 0.00 0.00 1.35
Fixed Asset Turnover
0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 2.18 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 148.65
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 269.89
Days Payable Outstanding (DPO)
0.00 0.00 167.42 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 -167.42 418.54
Capital & Investment Metrics
- - - -
Invested Capital
-0.14 51 -1.87 3.31
Invested Capital Turnover
0.00 0.00 0.42 8.28
Increase / (Decrease) in Invested Capital
0.00 51 -53 5.18
Enterprise Value (EV)
59 149 80 18
Market Capitalization
60 98 80 25
Book Value per Share
$0.27 ($0.04) ($0.33) $3.20
Tangible Book Value per Share
$0.27 ($0.04) ($0.33) $3.20
Total Capital
71 51 -1.51 10
Total Debt
0.00 0.17 0.82 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00
Net Debt
-71 0.14 0.46 -7.00
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.18 -0.19 -1.98 3.26
Debt-free Net Working Capital (DFNWC)
0.48 -0.16 -1.62 10
Net Working Capital (NWC)
0.48 -0.32 -2.44 10
Net Nonoperating Expense (NNE)
-0.01 -3.58 -1.01 24
Net Nonoperating Obligations (NNO)
-71 0.14 0.46 -7.00
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% -19.42% 54.45%
Debt-free Net Working Capital to Revenue
0.00% 0.00% -15.90% 171.56%
Net Working Capital to Revenue
0.00% 0.00% -23.96% 171.56%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 $0.36 $0.26 ($1.36)
Adjusted Weighted Average Basic Shares Outstanding
0.00 9.15M 6.90M 18.29M
Adjusted Diluted Earnings per Share
$0.00 $0.36 $0.26 ($1.36)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 9.15M 6.90M 18.29M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-0.06 -0.47 -1.79 -0.35
Normalized NOPAT Margin
0.00% 0.00% -17.53% -5.91%
Pre Tax Income Margin
0.00% 0.00% -7.54% -414.87%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 0.00 -27.57 -1,007.36
NOPAT to Interest Expense
0.00 0.00 -66.36 -14.37
EBIT Less CapEx to Interest Expense
0.00 0.00 -27.57 -1,007.36
NOPAT Less CapEx to Interest Expense
0.00 0.00 -66.36 -14.37
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-1,274.64% 0.00% -30.03% -2.39%

Quarterly Metrics And Ratios for AMCI Acquisition

This table displays calculated financial ratios and metrics derived from AMCI Acquisition's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
9,180,500.00 9,180,500.00 7,006,329.00 7,006,329.00 7,006,329.00 7,006,329.00 3,854,856.00 3,854,856.00 3,220,947.00 3,220,947.00 22,600,363.00
DEI Adjusted Shares Outstanding
9,180,500.00 9,180,500.00 7,006,329.00 7,006,329.00 7,006,329.00 7,006,329.00 3,854,856.00 3,854,856.00 3,220,947.00 3,220,947.00 22,600,363.00
DEI Earnings Per Adjusted Shares Outstanding
0.09 0.04 0.05 0.07 -0.29 -0.01 0.01 -0.69 -6.89 0.05 -0.01
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -41.37% -33.91% -32.93%
EBITDA Growth
0.00% -49.78% -13.22% 8.17% 6.96% 76.08% -14.16% -1,442.62% -12,194.36% 310.07% 4.01%
EBIT Growth
0.00% -49.78% -13.22% 8.17% 6.96% 76.08% -14.16% -1,442.62% -12,194.36% 310.07% 4.01%
NOPAT Growth
0.00% -49.78% -13.22% 8.17% -635.47% -120.92% -14.16% -979.84% 233.77% 124.21% 78.71%
Net Income Growth
0.00% -45.85% -45.68% -33.59% -351.77% -122.10% -93.89% -628.14% -1,003.85% 288.66% 23.23%
EPS Growth
0.00% -37.50% -40.00% -30.00% -375.00% -100.00% -16.67% -2,042.86% 59.09% 0.00% 0.00%
Operating Cash Flow Growth
0.00% 95.76% 100.00% 95.89% 2,114.55% 1,481.17% 0.00% 92.49% -1,041.71% -291.97% -330.93%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 199.86% 0.00% -750.73% 724.39% -124.41% -106.49% -1,122.52% -4,619.90%
Invested Capital Growth
0.00% 0.00% 0.00% -100.38% -103.69% -62.30% -227.56% 5,674.10% 277.28% 918.97% 928.86%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% -82.43% 0.00% 0.00% 0.00% -80.19% -20.89%
EBITDA Q/Q Growth
4.88% -25.28% 37.79% -23.87% 3.62% 67.79% 5.72% -1,573.77% -668.11% 100.55% -276.76%
EBIT Q/Q Growth
4.88% -25.28% 37.79% -23.87% 3.62% 67.79% 5.72% -1,573.77% -668.11% 100.55% -276.76%
NOPAT Q/Q Growth
4.88% -25.28% 37.79% -23.87% -661.83% 62.37% 5.72% -1,071.64% 194.38% -93.19% -186.46%
Net Income Q/Q Growth
5.65% -56.28% 9.59% 31.16% -500.57% 96.16% 168.69% -11,446.07% -737.24% 100.66% -220.69%
EPS Q/Q Growth
-20.00% -37.50% 20.00% 16.67% -414.29% 100.00% 25.00% -2,820.00% 93.38% 111.11% -200.00%
Operating Cash Flow Q/Q Growth
82.03% 49.56% 100.01% -335,000.00% 8,907.41% -65.42% 0.00% 0.00% -1,104,340.95% 92.95% -177.87%
Free Cash Flow Firm Q/Q Growth
100.00% 0.00% -46.87% 260,859.90% -29.98% -100.67% 11,708.85% -7,827.10% 81.39% -26.28% -29.88%
Invested Capital Q/Q Growth
-30.54% -100.57% 39.44% -59.43% -568.17% 74.84% -22.22% 2,813.10% -78.75% 16.22% 23.70%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 0.00% 0.00% 0.00% 6.43% 27.24% 0.00% 0.00% 47.70% 86.16% 80.09%
EBITDA Margin
0.00% 0.00% 0.00% 0.00% -1.73% -3.16% 0.00% 0.00% -361.72% 10.05% -22.45%
Operating Margin
0.00% 0.00% 0.00% 0.00% -19.48% -41.72% 0.00% 0.00% 44.44% 10.85% -16.70%
EBIT Margin
0.00% 0.00% 0.00% 0.00% -1.73% -3.16% 0.00% 0.00% -361.72% 10.05% -22.45%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% -19.71% -4.31% 0.00% 0.00% -371.15% 12.29% -18.75%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.39% 105.93% 100.00% 100.00% 100.02% 98.58% 99.07%
Interest Burden Percent
-422.34% -147.41% -259.67% -274.96% 1,138.37% 128.56% -13.89% 94.14% 102.59% 124.07% 84.30%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.42% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% -5.70% 0.00% 0.00% 0.00% 257.70% 34.01% -27.43%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% -212.53% 0.00% 0.00% 0.00% 993.27% 33.85% -26.84%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% -2.64% 0.00% 0.00% 0.00% -813.66% -29.58% 22.62%
Return on Equity (ROE)
4.78% 10.25% 4.46% 3.26% -8.34% -3.58% 2.99% -6.54% -555.95% 4.43% -4.81%
Cash Return on Invested Capital (CROIC)
-101.62% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -117.36% -167.08% -105.46% -98.11%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% -0.60% -1.08% 0.00% 0.00% -233.60% 3.63% -7.34%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% -6.90% -1.47% 0.00% 0.00% -239.69% 4.44% -6.13%
Return on Common Equity (ROCE)
0.01% -0.12% -0.08% -0.03% 0.46% 0.14% -0.15% 0.65% -555.95% 1.39% -1.42%
Return on Equity Simple (ROE_SIMPLE)
0.00% -422.95% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.19 -0.24 -0.15 -0.18 -1.39 -0.52 -0.17 -1.97 1.86 0.13 -0.11
NOPAT Margin
0.00% 0.00% 0.00% 0.00% -13.64% -29.20% 0.00% 0.00% 31.11% 10.70% -11.69%
Net Nonoperating Expense Percent (NNEP)
-724.02% 2.29% 2.06% 2.63% 206.83% 1.31% 0.56% -2.71% -735.57% 0.16% -0.59%
Return On Investment Capital (ROIC_SIMPLE)
118.33% 71.61% 45.13% 55.74% 92.14% 112.36% 29.51% 59.06% 18.03% 1.21% -1.06%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 93.57% 72.76% 0.00% 0.00% 52.30% 13.84% 19.91%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 15.92% 45.60% 0.00% 0.00% -7.96% 72.16% 94.36%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.81% 0.00% 0.00% 0.00% 1.94% 0.32%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 25.91% 68.96% 0.00% 0.00% 3.26% 75.31% 96.79%
Earnings before Interest and Taxes (EBIT)
-0.19 -0.24 -0.15 -0.18 -0.18 -0.06 -0.17 -2.82 -22 0.12 -0.21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.19 -0.24 -0.15 -0.18 -0.18 -0.06 -0.17 -2.82 -22 0.12 -0.21
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.47 1.68 10.92
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.47 1.68 10.92
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 7.83 6.77 0.00 0.00 4.26 3.27 22.91
Price to Earnings (P/E)
33.86 38.49 33.80 38.36 0.00 0.00 44.91 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.95% 2.60% 2.96% 2.61% 0.00% 0.00% 2.23% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.95 0.00 0.00 0.00 0.00 0.00 0.00 4.51 5.58 2.84 22.47
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 7.88 6.91 0.00 0.00 3.09 2.04 21.78
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 42.10 160.97
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 141.32 105.21 1,040.40 1,360.88 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 1.58 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.01 0.01 0.02 -0.35 0.10 0.11 0.14 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -1.01 -1.00 -0.42 0.01 -1.01 -1.01 -0.77 -0.82 -0.87 -0.84
Leverage Ratio
1.01 1.01 1.02 1.01 1.21 1.04 1.05 1.10 2.32 1.11 1.13
Compound Leverage Factor
-4.25 -1.49 -2.64 -2.78 13.76 1.34 -0.15 1.04 2.38 1.38 0.95
Debt to Total Capital
0.33% 0.56% 1.06% 1.80% -54.45% 9.05% 10.18% 12.19% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.33% 0.56% 1.06% 1.80% -54.45% 9.05% 10.18% 12.19% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
100.32% 100.65% 100.63% 100.62% 0.00% 102.60% 103.13% 121.41% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-0.64% -1.20% -1.69% -2.42% 154.45% -11.64% -13.31% -33.60% 100.00% 100.00% 100.00%
Debt to EBITDA
-0.24 -0.38 -0.71 -1.26 -1.11 -2.89 -2.22 -0.55 0.00 0.00 0.00
Net Debt to EBITDA
-0.20 67.80 66.64 68.87 -0.62 29.84 20.30 -0.55 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.24 -0.38 -0.71 -1.26 -0.46 -0.76 -2.22 -0.78 0.00 0.00 0.00
Net Debt to NOPAT
-0.20 67.80 66.64 68.87 -0.26 7.83 20.30 -0.78 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
152.03 84.89 49.07 35.77 5.39 22.90 10.66 4.42 9.69 11.15 71.31
Noncontrolling Interest Sharing Ratio
99.81% 101.21% 101.70% 101.00% 105.51% 104.03% 104.87% 109.95% 0.00% 68.68% 70.41%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.16 0.13 0.07 0.02 0.75 0.03 0.02 0.00 13.89 14.50 11.39
Quick Ratio
0.07 0.02 0.01 0.01 0.28 0.00 0.00 0.00 12.00 12.87 9.00
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.05 0.03 73 51 -0.34 0.23 -18 -3.32 -4.19 -5.45
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 -20.78 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 12.36 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 12.36 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.35 0.34 0.00 0.00 0.65 0.36 0.33
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.46 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.35 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 2.18 23.08 0.00 0.00 0.00 7.52 3.44
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 148.65 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 269.89 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 167.42 15.81 0.00 0.00 0.00 48.54 106.19
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 -167.42 -15.81 0.00 0.00 418.54 -48.54 -106.19
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
51 -0.29 -0.18 -0.28 -1.87 -0.47 -0.57 16 3.31 3.85 4.76
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.42 -31.57 0.00 0.00 8.28 3.18 2.35
Increase / (Decrease) in Invested Capital
0.00 -0.29 -0.18 -73 -53 -0.18 -0.40 16 5.18 4.32 5.34
Enterprise Value (EV)
149 101 78 79 80 83 47 70 18 11 107
Market Capitalization
98 100 77 78 80 81 45 49 25 18 113
Book Value per Share
($0.04) ($0.07) ($0.12) ($0.18) ($0.33) ($0.30) ($0.63) ($1.36) $3.20 $3.25 $0.46
Tangible Book Value per Share
($0.04) ($0.07) ($0.12) ($0.18) ($0.33) ($0.30) ($0.63) ($1.36) $3.20 $3.25 $0.46
Total Capital
51 51 52 53 -1.51 18 18 16 10 10 10
Total Debt
0.17 0.29 0.55 0.95 0.82 1.62 1.85 1.90 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.14 -51 -51 -52 0.46 -17 -17 1.90 -7.00 -6.63 -5.54
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.19 -0.34 -0.34 -0.33 -1.98 -0.47 -0.57 -3.34 3.26 3.80 4.71
Debt-free Net Working Capital (DFNWC)
-0.16 -0.33 -0.33 -0.33 -1.62 -0.47 -0.57 -3.34 10 10 9.25
Net Working Capital (NWC)
-0.32 -0.62 -0.87 -1.28 -2.44 -2.09 -2.42 -5.24 10 10 9.25
Net Nonoperating Expense (NNE)
-0.99 -0.59 -0.53 -0.68 0.62 -0.45 -0.19 0.68 24 -0.02 0.07
Net Nonoperating Obligations (NNO)
0.14 -51 -51 -52 0.46 -17 -17 1.90 -7.00 -6.63 -5.54
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% -19.42% -3.92% 0.00% 0.00% 54.45% 70.70% 95.85%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% -15.90% -3.88% 0.00% 0.00% 171.56% 194.14% 188.35%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% -23.96% -17.42% 0.00% 0.00% 171.56% 194.14% 188.35%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.08 $0.05 $0.06 $0.07 ($0.22) $0.04 $0.05 ($1.36) ($0.09) $0.01 ($0.01)
Adjusted Weighted Average Basic Shares Outstanding
9.15M 7.01M 7.01M 7.01M 18M 3.85M 3.85M 3.85M 18.29M 22.60M 22.60M
Adjusted Diluted Earnings per Share
$0.08 $0.05 $0.06 $0.07 ($0.22) $0.04 $0.05 ($1.36) ($0.09) $0.01 ($0.01)
Adjusted Weighted Average Diluted Shares Outstanding
9.15M 7.01M 7.01M 7.01M 18M 3.85M 3.85M 3.85M 18.29M 24.81M 22.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 7.01M 7.01M 7.01M 0.00 3.85M 3.85M 3.22M 0.00 22.60M 22.60M
Normalized Net Operating Profit after Tax (NOPAT)
-0.13 -0.17 -0.10 -0.13 -1.39 -0.52 -0.12 -1.97 1.86 0.13 -0.11
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% -13.64% -29.20% 0.00% 0.00% 31.11% 10.70% -11.69%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% -19.64% -4.06% 0.00% 0.00% -371.07% 12.47% -18.93%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 -3.43 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 -31.72 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -3.43 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -31.72 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -30.03% 0.00% 0.00% 0.00% -2.39% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

AMCI’s latest filing data shows a business undergoing a significant transition. The records identify the latest company as AMC Robotics Corp. under AMCI, while several earlier periods are labeled AlphaVest Acquisition Corp. under ATMV. Because of these ticker and company-name changes, comparisons across the full period should be treated cautiously, particularly where periods were restated.

Revenue has declined from the elevated levels reported in late 2025. Second-quarter 2026 revenue was $937,177, down from $1.18 million in the first quarter and $1.40 million in the second quarter of 2025. It was also substantially below the $5.98 million reported in the fourth quarter of 2025. Despite the lower revenue base, gross profit remained $750,607, representing an approximately 80% gross margin.

Profitability remains weak. Second-quarter operating expenses of $907,107 exceeded gross profit, producing an operating loss of $156,500. After other expenses and taxes, the company reported a net loss of $175,730, or $0.01 per diluted share. This reversed the $145,601 profit reported in the first quarter of 2026 and continued the pattern of volatile earnings seen in prior periods.

Cash flow is a significant concern. Operating cash flow was negative $1.09 million in the second quarter, compared with negative $391,580 in the first quarter. The company also spent $1 million on investing activities, resulting in a total quarterly cash decrease of $2.09 million. At the end of June, cash and equivalents stood at $4.54 million, down from $6.63 million at the end of March.

  • Strong gross margin in the latest quarter: Gross profit of $750,607 on $937,177 of revenue equates to an approximately 80% gross margin, suggesting favorable economics before operating overhead.
  • Low balance-sheet leverage: Total liabilities were only $920,567 at June 30, 2026, including no reported interest-bearing debt. This limits near-term interest and refinancing pressure.
  • Substantial liquidity relative to liabilities: Current assets of $10.14 million compared with current liabilities of $890,819 produced a current ratio of roughly 11.4, although much of the liquidity is tied up in receivables and other current assets rather than cash.
  • Positive shareholders’ equity: Total equity was $10.31 million at the end of the second quarter, a major improvement from the negative equity balances reported in the 2024 and 2025 periods.
  • Accounts receivable represent a large portion of assets: Receivables totaled $3.47 million, or approximately 34% of current assets. The ability to collect these balances will be important to future liquidity.
  • Investment holdings increased: The balance sheet reported $1 million of long-term investments in the second quarter, while investing cash outflows also totaled $1 million. The strategic purpose and liquidity of these investments are not clear from the supplied data.
  • Operating losses returned: The company moved from a $145,601 net profit in Q1 2026 to a $175,730 net loss in Q2, while operating income shifted from positive $128,539 to negative $156,500.
  • Revenue momentum weakened: Q2 revenue fell approximately 21% sequentially and 33% from Q2 2025. The decline raises questions about the sustainability of the company’s revenue growth and customer demand.
  • Cash burn accelerated: Quarterly operating cash outflow increased from $391,580 in Q1 to $1.09 million in Q2. At the latest burn rate, the $4.54 million cash balance would provide only a limited runway without improved operations or additional financing.
  • Large accumulated deficit: Retained earnings were negative $27.37 million at June 30, 2026. Although equity was positive because of a $37.68 million common-stock balance, the accumulated deficit reflects substantial historical losses.

Overall, AMCI’s balance sheet is currently stronger than the negative-equity structure shown in earlier periods, and the company reports very low liabilities. However, those positives are offset by declining revenue, renewed operating losses and rapidly increasing cash usage. Investors should focus on whether revenue stabilizes, whether selling and administrative costs can be reduced, and how long the current cash balance can support operations.

10/12/26 11:53 AM ETAI Generated. May Contain Errors.

AMCI Acquisition Financials - Frequently Asked Questions

According to the most recent income statement we have on file, AMCI Acquisition's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

AMCI Acquisition's net income appears to be on a downward trend, with a most recent value of -$24.82 million in 2025, falling from -$42.58 thousand in 2022. The previous period was -$776.96 thousand in 2024. See where experts think AMCI Acquisition is headed by visiting AMCI Acquisition's forecast page.

AMCI Acquisition's total operating income in 2025 was -$505.17 thousand, based on the following breakdown:
  • Total Gross Profit: $2.85 million
  • Total Operating Expenses: $3.36 million

Over the last 3 years, AMCI Acquisition's total revenue changed from $0.00 in 2022 to $5.98 million in 2025, a change of 598,084,700.0%.

In the past 11 quarters, AMCI Acquisition's cash and equivalents has ranged from $3.71 thousand in Q3 2025 to $6.63 million in Q1 2026, and is currently $4.54 million as of their latest financial filing in Q2 2026.

AMCI Acquisition had total debt of $0.00 at the end of 2025, a 100.0% decrease from 2024, and none in 2022.

Over the last 3 years, AMCI Acquisition's book value per share changed from 0.27 in 2022 to 3.20 in 2025, a change of 1,085.9%.



Financial statements for NASDAQ:AMCI last updated on 8/14/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners